Ranbaxy integration: Sun may drop some non-strategic units
Sun Pharma may discontinue certain non-strategic businesses as part of its integration process with Ranbaxy Laboratories, which it acquired in a USD 4 billion deal last year.
Nov 01, 2015, 10:58 AM ISTRanbaxy Lab, Sun Pharma gain up to 3.5% as CCI clears deal
Sun Pharma and Ranbaxy yesterday got CCI's approval for their long-pending USD 4-billion merger, but with a condition that they will have to modify the deal by divesting seven key products to address monopoly concerns.
Dec 09, 2014, 19:35 PM IST